Follow Chr. Hansen A/S

Tags

Continued strong growth in Q3

Continued strong growth in Q3

Press Releases   •   Jul 05, 2016 06:11 GMT

Strong organic revenue growth of 13% in the first nine months of 2015/16: Food Cultures & Enzymes (13%), Health & Nutrition (2%) and Natural Colors (20%). EBIT before special items increased by 18% to EUR 189 million. In Q3, organic growth reached 12% and EBIT before special items increased by 11% to EUR 71 million.

Chr. Hansen adjusts outlook after encouraging Q2 results

Chr. Hansen adjusts outlook after encouraging Q2 results

Press Releases   •   Apr 07, 2016 06:06 GMT

Based on the results for the first half of the year Chr. Hansen raises expectations for organic revenue growth for 2015-16 to 10-12% (previously 9-11%).

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Press Releases   •   Jan 14, 2016 07:08 GMT

Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.

Strong start to 2015/16: 14% organic revenue growth in Q1

Strong start to 2015/16: 14% organic revenue growth in Q1

Press Releases   •   Jan 14, 2016 07:02 GMT

We experienced a strong start to 2015/16 and 14% organic revenue growth in Q1 underlines our unique position in markets within microbial and natural color solutions with attractive growth opportunities.

Chr. Hansen to acquire Nutritional Physiology Company and expand its business in probiotics to the livestock industry

Chr. Hansen to acquire Nutritional Physiology Company and expand its business in probiotics to the livestock industry

Press Releases   •   Jan 13, 2016 17:04 GMT

At Chr. Hansen, the animal health and nutrition business supplies probiotics to various customers in the global livestock industry. Through the acquisition of US-based Nutritional Physiology Company (NPC), Chr. Hansen will further broaden this microbial platform and expand its presence into the beef cattle segment.

Very satisfactory annual result: 10% growth

Very satisfactory annual result: 10% growth

Press Releases   •   Oct 21, 2015 06:02 GMT

Chr. Hansen realizes strong organic growth of 10% in 2014/15, delivering at the upper end of the Nature's No. 1 growth ambition.

Chr. Hansen to acquire DIAL culture production and strain collection

Chr. Hansen to acquire DIAL culture production and strain collection

Press Releases   •   Oct 09, 2015 06:34 GMT

​Joint press release from Dairy Innovation Australia Ltd (DIAL) and Chr. Hansen A/S: The Board of Dairy Innovation Australia Ltd (DIAL) is pleased to announce that they have entered into a contract to finalize the sale of the DIAL culture production unit and strain collection to Chr. Hansen Holding A/S (Denmark) and Chr. Hansen Pty Ltd (Australia), a wholly owned subsidiary.

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

Press Releases   •   Sep 25, 2015 10:39 GMT

Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from one of the world’s largest clinical studies on probiotics now show that the probiotic strain named BB-12® can be part of the solution by improving bowel regularity.

New CFO appointed

New CFO appointed

Press Releases   •   Jul 07, 2015 06:33 GMT

Søren Westh Lonning has been appointed the new Chief Financial Officer (CFO) and member of the Executive Board of Chr. Hansen Holding A/S.

Encouraging performance in the first nine months

Encouraging performance in the first nine months

Press Releases   •   Jul 01, 2015 06:09 GMT

Chr. Hansen realizes strong organic growth of 9% in the first nine months of 2014/15, narrows organic revenue expectations to 8-9% and declares interim dividend to shareholders.

Chr. Hansen develops game-changing fermentation process for carmine

Chr. Hansen develops game-changing fermentation process for carmine

Press Releases   •   Jun 18, 2015 07:07 GMT

In collaboration with University of Copenhagen, Department of Plant and Environmental Sciences (KU) and Technical University of Denmark, Department of Systems Biology (DTU), researchers from Chr. Hansen have succeeded in producing carmine by a modern fermentation process. The first of a series of patents that protects the technology has been published today.

Jesper Allentoft, Executive Vice President, Stakeholder Relations retires from Chr. Hansen A/S. Ditte Marstrand Wulf appointed as successor.

Jesper Allentoft, Executive Vice President, Stakeholder Relations retires from Chr. Hansen A/S. Ditte Marstrand Wulf appointed as successor.

Press Releases   •   May 21, 2015 07:51 GMT

Jesper Allentoft has been with Chr. Hansen since 1 January, 2006 and is now retiring early at the age of 60. Ditte Marstrand Wulf will start as Group Vice President, Stakeholder Relations on 1 August, 2015.

New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

New clinical study indicates: probiotics may shorten duration of common cold and lower use of health care resources

Press Releases   •   May 21, 2015 06:57 GMT

With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

Press Releases   •   May 11, 2015 07:13 GMT

​A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.

Chr. Hansen brings breakthrough technology to Vitafoods Europe 2015

Chr. Hansen brings breakthrough technology to Vitafoods Europe 2015

Press Releases   •   Apr 23, 2015 08:00 GMT

The market for natural dietary supplements is booming and Chr. Hansen will present its growing portfolio of products at this year’s Vitafoods Europe, with focus on the ground-breaking technology LIFE GEL®, and the award-nominated product solution Mother’s 1st.

Chr. Hansen accelerates efforts within human microbiome

Chr. Hansen accelerates efforts within human microbiome

Press Releases   •   Apr 09, 2015 09:24 GMT

Establishes a new research and development consortium and secures access and commercialization rights to an important resource of strains

Strong performance keeps Chr. Hansen on track

Strong performance keeps Chr. Hansen on track

Press Releases   •   Apr 09, 2015 09:11 GMT

Strong organic revenue growth of 11% in the first half of 2014/15

New generation of cultures boosts flavor in fresh dairy

New generation of cultures boosts flavor in fresh dairy

Press Releases   •   Mar 11, 2015 12:58 GMT

Chr. Hansen launches “eXact® NG Flavor+, a culture that gives a creamy and rich dairy flavor with increasing diacetyl production during shelf life – without gas production.

Media no image

The importance of bacterial behavior

Press Releases   •   Dec 11, 2014 07:58 GMT

Chr. Hansen engages in global research for new and improved functional food products for the future.

Media no image

Chr. Hansen donates lab equipment to local schools

Press Releases   •   Dec 10, 2014 09:45 GMT

Corporate Social Responsibility was put into action when school children in Milwaukee, USA, received laboratory equipment and glassware that the company no longer needed.